Literature DB >> 26309021

Vascular risk factors aggravate the progression of Parkinson's disease: a five-year follow-up study in Chinese patients.

Hai Jun Li1, Ying Yu1, Ying Chen1, Hai Yan Liang1.   

Abstract

OBJECTIVE: Some studies have found that vascular risk factors were related to an increased risk of Parkinson's disease. In order to investigate the comorbidities of the vascular risk factors with PD and their impact on PD progression, we launched a five-year follow-up study in 247 outpatients with probable PD.
METHODS: The incidence of vascular risk factors including hypertension, diabetes, hypercholesterolemia, hyperhomocysteinemia and carotid atherosclerotic plaque analyzed. The Hoen and Yahr score with and without vascular risk factors were compared at initial and at final evaluation.
RESULTS: Multiple regression analysis showed that age, hypertension and hyperhomocysteinemia were significant variables that are associated with the Hoen and Yahr scales. Younger patients with hypertension or hyperhomocysteinemia showed a greater increasing in the Hoen and Yahr score. There were no significant correlations among the Hoen and Yahr score with sex, initial of the Hoen and Yahr score, diabetes, hypercholesterolemia or carotid atherosclerotic plaque.
CONCLUSION: The vascular risk factors are common comorbidities of PD. Younger, more educated patients are more likely to have quicker dyskinesia decline. In addition, hypertension and hyperhomocysteinemia may aggravate the progression of PD. The prevention and treatment of hypertension and hyperhomocysteinemia are important for PD patients.

Entities:  

Keywords:  Parkinson’s disease; cognition; progression; vascular risk factors

Year:  2015        PMID: 26309021      PMCID: PMC4537966     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  36 in total

Review 1.  Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.

Authors:  Bart F L van Nuenen; Thilo van Eimeren; Joyce P M van der Vegt; Carsten Buhmann; Christine Klein; Bastiaan R Bloem; Hartwig R Siebner
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

2.  Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-02-19       Impact factor: 17.088

Review 3.  The Parkinson's complex: parkinsonism is just the tip of the iceberg.

Authors:  J William Langston
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

4.  Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease.

Authors:  Lusine Danielyan; Roman Klein; Leah R Hanson; Marine Buadze; Matthias Schwab; Christoph H Gleiter; William H Frey
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.

Authors:  Zahra Mansouri; Masoumeh Sabetkasaei; Fatemeh Moradi; Fatemeh Masoudnia; Amin Ataie
Journal:  J Mol Neurosci       Date:  2012-03-15       Impact factor: 3.444

7.  The effect of vascular disease on late onset Parkinson's disease.

Authors:  S Papapetropoulos; J Ellul; A A Argyriou; P Talelli; E Chroni; T Papapetropoulos
Journal:  Eur J Neurol       Date:  2004-04       Impact factor: 6.089

8.  Diabetes is associated with postural instability and gait difficulty in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2013-02-23       Impact factor: 4.891

Review 9.  Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism.

Authors:  A Michotte
Journal:  Acta Neurol Belg       Date:  2003-09       Impact factor: 2.396

10.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more
  3 in total

1.  Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Nicolaas I Bohnen
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

2.  Altered Neuronal Firing Pattern of the Basal Ganglia Nucleus Plays a Role in Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease.

Authors:  Xiaoyu Li; Ping Zhuang; Yongjie Li
Journal:  Front Hum Neurosci       Date:  2015-11-25       Impact factor: 3.169

3.  Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.

Authors:  Diane M A Swallow; Michael A Lawton; Katherine A Grosset; Naveed Malek; Johannes Klein; Fahd Baig; Claudio Ruffmann; Nin P Bajaj; Roger A Barker; Yoav Ben-Shlomo; David J Burn; Thomas Foltynie; Huw R Morris; Nigel Williams; Nicholas W Wood; Michele T M Hu; Donald G Grosset
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-09-26       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.